Stock Screener App

Frei -

Installieren

7.58

4.11% -0.44

Leonabio Inc (LONA)

Überblick Nachrichten Preisverlauf Forum Prognose

Leonabio Inc Aktie (LONA) Neueste Nachrichten

A drug developer's New York fireside chat is set for Sept. 11 - Stock Titan

Perceptive Advisors LLC Expands LeonaBio Inc (LONA) Stake in Str - GuruFocus

Sermonix Pharmaceuticals Discloses Investment at LeonaBio, Inc. with 36.9% Stake - TradingView

Prefunded warrants drive Sermonix-led LeonaBio (LONA) share shakeup - Stock Titan

Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO), LeonaBio (LONA) and Solid Biosciences (SLDB) - The Globe and Mail

LeonaBio Reaches Key Phase 3 Enrollment Milestone - TipRanks

Perceptive's LeonaBio (NASDAQ: LONA) stake nears its ownership limit - Stock Titan

Anders Hove reports new passive stake in LeonaBio (LONA) - Stock Titan

LONA Maintained by Mizuho -- Price Target Lowered to $15.00 - GuruFocus

Mizuho lowers LeonaBio stock price target on higher OpEx By Investing.com - Investing.com Nigeria

Mizuho lowers LeonaBio stock price target on higher OpEx - Investing.com

Analysts Are Bullish on These Healthcare Stocks: Cooper Co (COO), LeonaBio (LONA) - The Globe and Mail

symbol__ Stock Quote Price and Forecast - CNN

LeonaBio Reports Narrower Quarter Loss as Trial Progresses - sekbernews.id

LeonaBio: ELAINE-3 Enrollment Reaches 495 Of About 600 Patients As Up To $146 Million Of Warrant Proceeds Could Support Upcoming Milestones - Pulse 2.0

LeonaBio (LONA) Market Close: Closes 3.19% Higher at $7.96 at the Close; Level Check: the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotLow Volatility Picks - vinanet.vn

LeonaBio price target lowered to $17 from $18 at Citizens - TipRanks

LeonaBio Inc. (LONA) Climbs 2.84% to $8.19 as Biotech Buyers Target $8.60 ResistanceWedge Breakout - Vinanet

LeonaBio, Inc. (NASDAQ: LONA) Share Price, LONA Stock News, LONA Share Price & Updates - Kalkine

LONA Maintained by Citizens -- Price Target Lowered to $17.00 - GuruFocus

LeonaBio beats Q2 loss forecast as Phase 3 ELAINE-3 trial advances - Yahoo Finance

LeonaBio beats second quarter loss estimates By Investing.com - Investing.com Nigeria

LeonaBio beats second quarter loss estimates - Investing.com

LeonaBio Inc (LONA) Q2 Results Highlight Challenges for Valuatio - GuruFocus

Citizens lowers LeonaBio stock price target to $17 on valuation By Investing.com - Investing.com Canada

LeonaBio Q2 Results: EPS beats estimate, losses narrow 55% YoY - scanx.trade

LeonaBio Narrows Q2 Loss - marketscreener.com

LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times

LeonaBio (LONA) loss widens as cash burn rises and going concern risk emerges - Stock Titan

LeonaBio Q2 net loss widens on higher R&D spending - TradingView

LeonaBio Posts $19.0 Million Q2 Loss as ELAINE-3 Enrollment Advances - Quiver Quantitative

LeonaBio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

LeonaBio’s lasofoxifene to be featured at breast cancer summit By Investing.com - Investing.com Nigeria

LeonaBio’s lasofoxifene to be featured at breast cancer summit - Investing.com

LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer - The Manila Times

LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), - GlobeNewswire

LONA Q1 2026 Earnings: Narrowed Loss Beats Estimates, Shares RisePost-Earnings Reaction - vinanet.vn

LONA Q1 2026 Earnings: Narrower-Than-Expected Loss Points to Cost DisciplineEPS Growth Report - vinanet.vn

LONA: LeonaBio, Inc.12 Month EPS - Zacks Investment Research

LeonaBio Inc. (LONA) Slips 2.74% to $7.45 as Biotech Stock Nears Key SupportDividend ETF - vinanet.vn

LeonaBio Inc expected to post a loss of $1.26 a shareEarnings Preview - TradingView

LeonaBio Inc. (LONA) Q1 2026 Earnings: Narrower-than-Expected Loss Driven by Expense ManagementRevenue Estimate Trend - vinanet.vn

LeonaBio Inc. (LONA) Advances 2.08%: Biotech Stock Tests Mid-Range Resistance After Oversold BounceBreakaway Gap - dars.gov.et

LONA|LeonaBio Ord Shs|Price:7.275|Chg%:-0.115 - TradingKey

LeonaBio Ord Shs (LONA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

LeonaBio Ord Shs (LONA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

LeonaBio, Inc. Revenue Breakdown – NASDAQ:LONA - TradingView

LeonaBio Ord Shs (LONA) Institutional Confidence - TradingKey

LONA Q1 2026 Earnings: EPS Surprises to the Upside as Biotech Advances PipelineBook Value Growth - vinanet.vn

LONA Q1 2026 Earnings: Narrowed Loss Exceeds Expectations, Stock Rises 5.7%Consensus Miss Rate - vinanet.vn

LONA Q1 2026 Earnings: EPS Beat Drives 4.85% Stock Surge Despite Zero RevenueNon-GAAP Earnings - vinanet.vn

LeonaBio Inc. (LONA) Drops 7.55% as Selling Pressure Intensifies, Testing Key SupportMomentum Stock Picks - dars.gov.et

LONA Q1 2026 Earnings: Narrowed Loss Beats Expectations, but Stock Drops 7.55%Earnings Recovery Stocks - vinanet.vn

Mizuho Securities Remains a Buy on LeonaBio (LONA) - The Globe and Mail

RPRX

$60.13

0.71%

INSM

$129.12

2.84%

ROIV

$41.64

0.61%

ALNY

$255.32

1.75%

ONC

$348.96

0.72%

RVMD

$209.70

1.11%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters